Frontiers in microbiology : from antibiotics to AIDS
著者
書誌事項
Frontiers in microbiology : from antibiotics to AIDS
(New perspectives in clinical microbiology, 13)
Nijhoff, 1987
大学図書館所蔵 全2件
  青森
  岩手
  宮城
  秋田
  山形
  福島
  茨城
  栃木
  群馬
  埼玉
  千葉
  東京
  神奈川
  新潟
  富山
  石川
  福井
  山梨
  長野
  岐阜
  静岡
  愛知
  三重
  滋賀
  京都
  大阪
  兵庫
  奈良
  和歌山
  鳥取
  島根
  岡山
  広島
  山口
  徳島
  香川
  愛媛
  高知
  福岡
  佐賀
  長崎
  熊本
  大分
  宮崎
  鹿児島
  沖縄
  韓国
  中国
  タイ
  イギリス
  ドイツ
  スイス
  フランス
  ベルギー
  オランダ
  スウェーデン
  ノルウェー
  アメリカ
注記
Proceedings of the International Symposium on Frontiers in Microbiology, held Nov. 1986 in Leuven, and sponsored by the National Fonds voor Wetenschappelijk Onderzoek and other organizations
Includes bibliographies
内容説明・目次
内容説明
The International Symposium on Frontiers in Microbiology has been de dicated to Prof. P. De Somer, whom I succeeded shortly after his death on 17 June 1985 as Rector of this now more than 560-year old University. When Prof. De Somer became the head of the University he started to remodel it, giving our old Alma Mater a more transparent administrative structure, strengthening its scientific and cultural autonomy, and establishing close links with the most prestigious national and foreign institutions. This made De Somer to one of the greatest, if not the greatest, of rectors in the history of Belgian Universities. He was a great leader, a perfect organizer, a clever negotiator, and a brilliant orator. In his speeches one immediately sensed his intuitive cognition and witty evaluation of the values of life. He knew perfectly well how to persuade the unwilling and to disenchant the illusionist. Sometimes a visionary himself, he would not pursue his ideas unless there was a chance of success. As innovative Prof. P. De Somer was in providing to this University a new face, or should I say facelifting, as international is his reputation as the founder, and, since its inception, only director, of the Rega Institute. Built now more than 30 years ago, the Rega Institute has re mained one of the world's leading centers in microbiological research.
目次
A. Review Lectures by Invited Speakers.- Section I: Chemotherapy.- - Introduction to Section I.- - ?-Lactam antibiotics as carbonyl donors of the active-site serine ?-lactamases, DD-peptidases and LL-peptidases.- - New antifungal agents: a result of target-oriented drug design.- - Antiviral chemotherapy: design or serendipity ?.- Section II: Intestinal Microflora.- - Introduction to Section II.- - The indigenous gastrointestinal microflora.- - Metabolism of endogenous substances.- - Seeking explanations for pharmacological and toxicological phenomena in the metabolic reactions of the intestinal flora.- Section III: Humoral Factors in Immunity.- - Introduction to Section III.- - Mechanisms of natural resistance.- - Regulation of cell growth by interferon and tumor necrosis factor.- - The role of interleukin-1 in mediating host defense mechanisms.- Section IV: Tumor Immunity.- - Introduction to Section IV.- - Mechanisms of resistance to viruses and tumors, and the development of vaccines.- - Total lymphoid irradiation.- Section V: New Horizons in Virus Research.- - Introduction to Section V.- - Perspectives in disease prevention by vaccines.- - The challenge of chronic virus infections.- - Structure and function of the genome of HTLV-III and related viruses: current concepts on the role of HTLV-III in the pathogenesis of AIDS.- B. Contributions from the Rega Institute.- I. Research Unit.- - Synthesis and activity of some new cephalosporins.- - Incorporation of nucleoside analogues into oligonucleotides.- - 2?-5?-Oligoadenylates (2-5A) as mediators of interferon action. Synthesis and biological activity of new 2-5A analogues.- II. Research Unit.- - Cloning and expression of an rRNA methylase gene in Streptomyces venezuelae phage VWB.- - Coprostanic acids and a C29-dicarboxylic bile acid in peroxisomal diseases.- - Bile acid desulfation by the gut microflora.- - Steroid desulfation by the gut microflora.- - Biohydrogenation of fatty acids by intestinal bacteria.- - Classification of the genus Eubacterium.- - Isolation and characteristics of Clostridium HDCA-1, nova species.- III. Research Unit.- - Heterogeneity of recombinant murine interferon-? (MuIFN-?).- - Monoclonal antibodies against murine interferon-? and their use to investigate the role of endogenous interferon-? invivo.- - The interrelationship between interleukin-1, interferon-? and hemopoietic growth factors.- - Studies on gene expression in Streptomyceslividans.- IV. Research Unit.- - The influence of local immune suppression on polyoma virus-induced vascular tumors.- - Induction of transplantation tolerance after total lymphoid irradiation: influence of thymus transplantation or blood transfusions.- V. Research Unit.- - Mechanism of antiviral action of 5-substituted 2?-deoxyuridines: (E)-5-(2-iodovinyl)-2?-deoxyuridine (IVDU) as compared to its carbocyclic analogue (C-IVDU).- - Therapeutic implications of the unusually long half-life of (E)-5-(2-bromovinyl)uracil (BVUra) in vivo.- - S-Adenosyl-L-homocysteine hydrolase as target enzyme for antiviral agents: studies with adenosine kinase-deficient rat cells.- - Antiviral activity of (S)-9-(3-hydroxy-2-phosphonylmethoxypropyl)-adenine [(S)-HPMPA].- - Selective inhibitory effects of (S)-9-(3-hydroxy-2-phosphonyl-methoxypropyl)adenine and 2?-nor-cGMP on the replication of adenovirus invitro.- - In search of antiviral compounds against the AIDS virus.
「Nielsen BookData」 より